爱德华生命科学

EW NYSE
183.93
-0.71
-0.38%
盘后: 184.63 +0.7 +0.38% 19:16 06/14 EDT
开盘
184.55
昨收
184.64
最高
184.63
最低
182.49
成交量
107.79万
成交均量(3M)
124.20万
52周最高
197.86
52周最低
134.53
换手率
0.52%
市值
383.50亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供爱德华生命科学 EW股票价格,爱德华生命科学股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The Company is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan and Rest of World. Its products are categorized into three areas: Transcatheter Heart Valve Therapy, Surgical Heart Valve Therapy and Critical Care. It also develops hemodynamic monitoring systems that are used to measure a patient's cardiovascular function in the hospital setting. It is developing products, such as the Edwards SAPIEN 3 Ultra System and Edwards SAPIEN XT transcatheter heart valve, among others. Its Transcatheter Heart Valve Therapy and Surgical Heart Valve Therapy products are manufactured in the United States, Singapore and Switzerland. Critical Care products are manufactured in its facilities located in Puerto Rico and the Dominican Republic.
展开 >

最近浏览

名称
价格
涨跌幅